Corrigendum to “Analysis of Central Nervous System Efficacy in the J-Alex Study of Alectinib Versus Crizotinib in ALK-positive Non-Small-Cell Lung Cancer” [Lung Cancer 121 (July) (2018) Pages 37–40]
Lung Cancer - Netherlands
doi 10.1016/j.lungcan.2019.04.012
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Elsevier BV